STAT+: A RAPID proposal for breakthrough coverage, and nurses push back on AI 

The legal basis for the $500 checks, and who would get them, isn't entirely clear.

Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly raising the long-term risk of new tumors

This week on "The Readout LOUD" podcast: Two experimental drugs were heralded as the next era in heart disease treatment — why did they fail?

There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean doctors have reconsidered.

Nominees for top federal health roles to face Congress, and Trump officials are betting on AI to help save rural health care.

UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout

A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks

An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around strategies to treat patients and a majority also report that clinical trials…